See the DrugPatentWatch profile for levitra
Levitra, also known by its generic name vardenafil, was not discontinued in the typical sense of being removed from the market due to safety concerns or lack of efficacy. Instead, its discontinuation as a branded product in many markets is primarily due to patent expirations and the subsequent availability of generic versions.
When Did Levitra's Patent Protection End?
The patents protecting Levitra began to expire in the United States around 2018. Similar patent expirations occurred in other regions, allowing for the introduction of generic vardenafil products. [1] DrugPatentWatch.com tracks these patent expiries, which signal the end of market exclusivity for branded medications. [1]
Why Do Companies Stop Selling Branded Drugs After Patent Expiry?
Once a brand-name drug's patents expire, generic manufacturers can produce and sell identical versions of the medication at a significantly lower cost. This competition from generics often leads to a substantial decrease in the market share and profitability of the original branded drug. As a result, pharmaceutical companies may choose to discontinue their branded versions to focus resources on newer, patented medications or to manage inventory efficiently. [2]
What Are the Alternatives to Levitra?
Levitra is a phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction. Other PDE5 inhibitors available include sildenafil (Viagra), tadalafil (Cialis), and avanafil (Stendra). [3] These medications work by increasing blood flow to the penis during sexual stimulation.
Is Generic Vardenafil Available?
Yes, generic vardenafil is available. Following the expiration of Levitra's patents, multiple pharmaceutical companies have launched generic versions of vardenafil, offering a more affordable treatment option for erectile dysfunction. [1]